S&P 500 7,499 -0.97% Nasdaq 25,691 -2.20% Dow Jones 52,219 -0.84% FTSE 100 10,707 +1.27% DAX 25,027 +0.45% Nikkei 225 66,423 -0.62% Hang Seng 25,211 +0.81% WTI Crude 90.37 +8.58% Gold 4,093 +2.06% US 10-Year Treasury Yield 4.657 +1.93% S&P 500 7,499 -0.97% Nasdaq 25,691 -2.20% Dow Jones 52,219 -0.84% FTSE 100 10,707 +1.27% DAX 25,027 +0.45% Nikkei 225 66,423 -0.62% Hang Seng 25,211 +0.81% WTI Crude 90.37 +8.58% Gold 4,093 +2.06% US 10-Year Treasury Yield 4.657 +1.93%

LATEST

The Rise And Rise Of Billion-Dollar-Plus Rounds●Path opened for Malaysian firms to pursue secondary share listings in Hong Kong●Is On-Prem Making A Comeback?●Exclusive: Coalesce buys Workstreet as cybersecurity challenges proliferate in age of AI●Infosys Q1 results: Profit up 12% YoY to ₹7,769 crore●IndiGo Q1 results: Airline slips into ₹238 crore loss amid cost pressures; revenue rises 20% YoY●Mobileye founder Shashua plans to step down as CEO●CBN: Credit to private sector rises to N83.26 trillion in June 2026●The Rise And Rise Of Billion-Dollar-Plus Rounds●Path opened for Malaysian firms to pursue secondary share listings in Hong Kong●Is On-Prem Making A Comeback?●Exclusive: Coalesce buys Workstreet as cybersecurity challenges proliferate in age of AI●Infosys Q1 results: Profit up 12% YoY to ₹7,769 crore●IndiGo Q1 results: Airline slips into ₹238 crore loss amid cost pressures; revenue rises 20% YoY●Mobileye founder Shashua plans to step down as CEO●CBN: Credit to private sector rises to N83.26 trillion in June 2026●

Front Page

Russia’s Amazon-style retail giant Wildberries is now in Ukraine’s crosshairs. Here's why

US Top News and Analysis · 1h ago · 🇷🇺 Russia

Russia’s Amazon-style retail giant Wildberries is now in Ukraine’s crosshairs. Here's why

Ukraine has ratcheted up its attacks on Russia's Amazon-style retail giant Wildberries, signaling a new phase in the war.

Read the full story at US Top News and Analysis →

More Front Page

Ozempic face? Botox maker reports boost from 'sagging face' trend

US Top News and Analysis · 29m ago

Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials

US Top News and Analysis · 32m ago

VAT cut to be applied to Manx electricity bills

BBC News · 37m ago

Google slapped with $1 billion fine under landmark EU digital law

US Top News and Analysis · 52m ago